We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

57 hedge funds and large institutions have $20.2M invested in Perspective Therapeutics in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 16 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

389% more capital invested

Capital invested by funds: $4.12M → $20.2M (+$16.1M)

300% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 4

175% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 8

33% more funds holding

Funds holding: 43 → 57 (+14)

0.33% more ownership

Funds ownership: 0.99% → 1.31% (+0.33%)

Holders
57
Holders Change
+14
Holders Change %
+32.56%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
16
Reduced
4
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$5.16M
2
Renaissance Technologies
Renaissance Technologies
New York
+$2.89M
3
BlackRock
BlackRock
New York
+$2.85M
4
PCM
Perkins Capital Management
Minnesota
+$1.36M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$998K

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$87K
2
UBS Group
UBS Group
Switzerland
-$74.2K
3
VF
Virtu Financial
New York
-$72.3K
4
Squarepoint
Squarepoint
New York
-$54K
5
TRCT
Tower Research Capital (TRC)
New York
-$53.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$6.77M +$5.16M +341,341 +122%
Renaissance Technologies
2
Renaissance Technologies
New York
$3.55M +$2.89M +191,170 +142%
BlackRock
3
BlackRock
New York
$3.31M +$2.85M +188,490 +163%
PCM
4
Perkins Capital Management
Minnesota
$1.52M +$1.36M +89,900 +180%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$1.07M +$998K +66,049 +204%
HPWM
6
Highland Private Wealth Management
Washington
$923K +$357K +23,654 +39%
BCM
7
Bridgeway Capital Management
Texas
$582K +$529K +35,000 +190%
BA
8
Bard Associates
Illinois
$417K +$578K +38,300 New
Northern Trust
9
Northern Trust
Illinois
$309K +$222K +14,668 +107%
VF
10
Virtu Financial
New York
$194K -$72.3K -4,785 -21%
MS
11
Maven Securities
Jersey
$167K +$227K +15,000 New
Citadel Advisors
12
Citadel Advisors
Florida
$134K +$41.4K +2,742 +29%
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$128K – – –
Creative Planning
14
Creative Planning
Kansas
$125K +$20.9K +1,381 +14%
CWM
15
Cahaba Wealth Management
Georgia
$114K – – –
Two Sigma Investments
16
Two Sigma Investments
New York
$69K +$95.9K +6,349 New
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$67K +$92.9K +6,150 New
Charles Schwab
18
Charles Schwab
California
$61K +$83.8K +5,547 New
CAG
19
Crestwood Advisors Group
Massachusetts
$60K – – –
Two Sigma Advisers
20
Two Sigma Advisers
New York
$56K +$78.1K +5,170 New
Capstone Investment Advisors
21
Capstone Investment Advisors
New York
$55K +$76.2K +5,047 New
Cerity Partners
22
Cerity Partners
New York
$44K – – –
Commonwealth Equity Services
23
Commonwealth Equity Services
Massachusetts
$43K +$1.51K +100 +3%
AF
24
Advisornet Financial
Minnesota
$34K +$10.3K +685 +29%
CPIG
25
Chicago Partners Investment Group
Illinois
$33K – – –
1
2 3

CATX Hedge Fund Activity: Q1 2021 in Review

57 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q1 2021, worth a combined $20.2M — up 389% from $4.12M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CATX positions and 8 closed out — a net gain of 14 holders — while 16 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $5.16M. The largest seller was Anson Funds Management, exiting entirely with an estimated $87K sold.

  • 57 institutional investors held Perspective Therapeutics (CATX) as of Q1 2021, up from 43 in Q4 2020.
  • Funds reported $20.2M of Perspective Therapeutics stock for Q1 2021, up 389% quarter-over-quarter.
  • 22 funds opened new Perspective Therapeutics positions in Q1 2021 and 8 closed out, a net change of +14 holders.
  • The largest Perspective Therapeutics buyer in Q1 2021 was Vanguard Group, an estimated $5.16M added.
  • The largest Perspective Therapeutics seller in Q1 2021 was Anson Funds Management, an estimated $87K sold.

Based on aggregated 13F filings for Q1 2021.